Bruker Cellular Analysis, Inc. Quarterly Deferred Tax Assets, Valuation Allowance in USD from Q4 2018 to Q4 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary
Bruker Cellular Analysis, Inc. quarterly Deferred Tax Assets, Valuation Allowance history and growth rate from Q4 2018 to Q4 2022.
  • Bruker Cellular Analysis, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending December 31, 2022 was $124M, a 20.8% increase year-over-year.
Deferred Tax Assets, Valuation Allowance, Quarterly (USD)
Deferred Tax Assets, Valuation Allowance, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q4 2022 $124M +$21.4M +20.8% Dec 31, 2022 10-K 2023-02-23
Q4 2021 $103M +$41M +66.3% Dec 31, 2021 10-K 2023-02-23
Q4 2020 $61.8M +$16.3M +35.8% Dec 31, 2020 10-K 2023-02-23
Q4 2019 $45.5M +$5.23M +13% Dec 31, 2019 10-K 2022-02-28
Q4 2018 $40.3M Dec 31, 2018 10-K 2021-03-12
* An asterisk sign (*) next to the value indicates that the value is likely invalid.